ReThink Medical

company

About

ReThink Medical is developing a wrist-worn monitoring device designed to predict and prevent heart failure hospitalizations.

  • 11 - 50

Details

Last Funding Type
Grant
Last Funding Money Raised
$188K
Industries
Health Care,Medical,Medical Device,Wearables
Founded date
Jan 1, 2010
Number Of Employee
11 - 50
Operating Status
Active

ReThink Medical is a medical device and digital health company developing a wrist-worn monitoring device.
Our technology is designed to predict and prevent heart failure hospitalizations through compliance-centric continuous physiologic monitoring & machine learning.
Our product, CorBand™ uses state of the art algorithms and artificial intelligence to potentially detect worsening conditions weeks in advance - even before noticeable symptoms.
Data-driven therapy can allow ample time for proper treatment to prevent hospitalization, improve quality of life, and save billions in healthcare costs.
We've designed a proactive approach to managing heart failure patients with a focus on compliance, simplicity, and accuracy.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
$5.18M
ReThink Medical has raised a total of $5.18M in funding over 2 rounds. Their latest funding was raised on May 1, 2017 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
May 1, 2017 Series A $3.50M 1 Detail
Sep 1, 2016 Grant $1.50M 1 Detail
May 1, 2014 Grant $188K 1 Detail

Investors

Number of Lead Investors
Number of Investors
2
ReThink Medical is funded by 2 investors. Norwich Ventures and National Institutes of Health are the most recent investors.
Investor Name Lead Investor Funding Round
Norwich Ventures Series A
National Institutes of Health Grant